FIRST LINE TREATMENT
Clinical trials for FIRST LINE TREATMENT explained in plain language.
Never miss a new study
Get alerted when new FIRST LINE TREATMENT trials appear
Sign up with your email to follow new studies for FIRST LINE TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat colon cancer? early trial launches
Disease control Recruiting nowThis early-phase study is testing whether a new drug called SAR445877, when added to standard chemotherapy and a targeted therapy, is safe for people with advanced colorectal cancer that hasn't spread widely yet. About 41 adults will take part. The main goal is to find any side e…
Matched conditions: FIRST LINE TREATMENT
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New immunotherapy drug could be first defense against advanced skin cancer
Disease control Recruiting nowThis phase 2 trial is testing the drug cemiplimab as a first-line treatment for people with advanced basal cell carcinoma who have not received prior therapy. The study will enroll 34 participants and measure how many patients see their tumors shrink or disappear after six months…
Matched conditions: FIRST LINE TREATMENT
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC